Regeneron Pharmaceuticals Inc. buy Evercore ISI
Start price
24.10.24
/
50%
€859.80
Target price
24.10.25
€1,087.7
Performance (%)
-42.02%
End price
25.10.25
€498.50
Summary
This prediction ended on 25.10.25 with a price of €498.50. Massive losses of -42.02% were the result for the BUY prediction by Evercore_ISI. Dividends of €2.60 are taken into consideration when calculating the performance. Evercore_ISI has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 2.399% | 2.399% | -9.305% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Evercore_ISI for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target lowered by analysts at Evercore ISI from $1,250.00 to $1,175.00. They now have an "outperform" rating on the stock.
Ratings data for REGN provided by MarketBeat
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von Evercore_ISI gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Evercore_ISI for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€899.00
16.05.24
16.05.24
-
16.05.25
16.05.25
-41.09%
17.05.25
17.05.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€909.80
14.05.24
14.05.24
€1,064.2
14.05.25
14.05.25
-43.88%
15.05.25
15.05.25